Surface Oncology

Please note: The information displayed on this page might be outdated.
Surface Oncology: Surface Oncology is developing next-generation antibody therapies focused on the tumor microenvironment with lead programs targeting CD73, CD39, IL-27 and CD47. We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Our diverse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families. Surface’s pipeline spans compelling areas of discovery and development across four key areas of immune modulators to: activate both macrophages and natural killer cells, inhibit or deplete regulatory T cells and block suppressive cell signaling molecules, including cytokines and metabolites.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - New England
Disease Space
Immuno-Oncology
Listing
Public, USA
Market Cap
100MM - 500MM
Website:
Profiles:
Address:
50 Hampshire Street
8th Floor
Cambridge, MA 02139
United States

Company Participants at Class of 2018 Biotech IPO Investor Day

  • Jeffrey J. Goater, CEO/Director/President/Secretary
  • Jessica Fees, CFO/Chief Accounting Officer/Senior VP, Divisional
  • Seth Lewis

Top 10 Holders of Surface Oncology, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Atlas Venture Associates IX LLC 10.40 2,945,453 21.53 13F 12/31/20
ARK Investment Management LLC 8.98 2,542,391 18.58 13F 12/31/20
VR Adviser LLC 5.09 1,442,895 10.55 13F 12/31/20
The Vanguard Group, Inc. 3.90 1,104,080 8.07 Funds 3/31/21
Vanguard Group, Inc. (Subfiler) 3.54 1,001,502 7.32 13F 12/31/20
Ghost Tree Capital LLC 3.53 1,000,000 7.31 13F 12/31/20
Farallon Capital Management LLC 3.53 1,000,000 7.31 13F 12/31/20
Acuta Capital Partners LLC 3.53 999,500 7.31 13F 12/31/20
Fidelity Management & Research Co. LLC 3.13 885,265 6.47 13F 12/31/20
Morgan Stanley Smith Barney LLC 2.76 782,678 5.72 13F 12/31/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.